Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Innoviva (INVA) Shares Issued (2016 - 2026)

Innoviva filings provide 16 years of Shares Issued readings, the most recent being $10.7 million for Q3 2025.

On a quarterly basis, Shares Issued rose 1124.26% to $10.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.1 million, a 703.37% increase, with the full-year FY2025 number at $2.6 million, up 74.15% from a year prior.
Shares Issued hit $10.7 million in Q3 2025 for Innoviva, up from $1.3 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $10.7 million in Q3 2025 to a low of $60000.0 in Q2 2021.
Median Shares Issued over the past 5 years was $250000.0 (2025), compared with a mean of $1.1 million.
The widest YoY moves for Shares Issued: up 12400.0% in 2021, down 69.54% in 2021.
Innoviva's Shares Issued stood at $123000.0 in 2021, then surged by 178.05% to $342000.0 in 2022, then tumbled by 67.54% to $111000.0 in 2023, then soared by 687.39% to $874000.0 in 2024, then skyrocketed by 1124.26% to $10.7 million in 2025.
The last three reported values for Shares Issued were $10.7 million (Q3 2025), $1.3 million (Q2 2025), and $250000.0 (Q1 2025) per Business Quant data.